The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((4-((4-oxo-4-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)butanoyl)oxy)but-2-yn-1-yl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole-2-oxide ID: ALA4587605
PubChem CID: 155566612
Max Phase: Preclinical
Molecular Formula: C30H30F3N5O6S
Molecular Weight: 645.66
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCC(=O)N1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1)OCC#CCOc1c[n+]([O-])on1
Standard InChI: InChI=1S/C30H30F3N5O6S/c31-30(32,33)22-8-9-26-24(20-22)37(23-6-1-2-7-25(23)45-26)13-5-12-35-14-16-36(17-15-35)28(39)10-11-29(40)43-19-4-3-18-42-27-21-38(41)44-34-27/h1-2,6-9,20-21H,5,10-19H2
Standard InChI Key: JNJFTVFFUYLQJD-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 49 0 0 0 0 0 0 0 0999 V2000
5.9523 -18.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6657 -18.5510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3791 -18.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3791 -19.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6657 -20.2023 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.9523 -19.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2375 -20.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5237 -19.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5211 -18.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2344 -18.5488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0970 -20.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8104 -19.7838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8077 -18.9641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0939 -18.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5208 -18.5535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5208 -17.7282 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.2381 -18.9641 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.2381 -18.1387 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.6657 -17.7258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3788 -17.3110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3788 -16.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0919 -16.0752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0919 -15.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8092 -14.8394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5222 -15.2500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5222 -16.0752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8092 -16.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2352 -14.8394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2352 -14.0142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9525 -15.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6656 -14.8394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3787 -15.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0959 -14.8394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8090 -15.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5221 -14.8394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2352 -14.4247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9524 -14.0142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6656 -14.4247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3786 -14.0142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4685 -13.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2717 -13.0216 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6861 -13.7384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1347 -14.3519 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6864 -12.3086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3787 -16.0752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 1 0
1 6 2 0
6 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
1 10 1 0
4 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
3 14 1 0
13 15 1 0
15 16 1 0
15 17 1 0
15 18 1 0
2 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
23 22 1 0
24 23 1 0
25 24 1 0
26 25 1 0
27 26 1 0
22 27 1 0
25 28 1 0
28 29 2 0
28 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 3 0
36 37 1 0
37 38 1 0
38 39 1 0
40 39 1 0
40 41 2 0
41 42 1 0
42 43 1 0
43 39 2 0
41 44 1 0
32 45 2 0
M CHG 2 41 1 44 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 645.66Molecular Weight (Monoisotopic): 645.1869AlogP: 3.87#Rotatable Bonds: 10Polar Surface Area: 115.29Molecular Species: NEUTRALHBA: 10HBD: ┄#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.28CX Basic pKa: 6.82CX LogP: 3.18CX LogD: 3.07Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.18Np Likeness Score: -1.29
References 1. Gao Y, Sun TY, Bai WF, Bai CG.. (2019) Design, synthesis and evaluation of novel phenothiazine derivatives as inhibitors of breast cancer stem cells., 183 [PMID:31541872 ] [10.1016/j.ejmech.2019.111692 ]